• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines N-arylpiperazines

1-(2-Thiazolyl)piperazinedihydrochloride: A Comprehensive Overview

1-(2-Thiazolyl)piperazinedihydrochloride (CAS No. 492431-13-7) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as thiazolylpiperazine dihydrochloride, is a derivative of piperazine and thiazole, two important heterocyclic compounds with a wide range of biological activities. The unique structural features of 1-(2-Thiazolyl)piperazinedihydrochloride make it an attractive candidate for various therapeutic applications, particularly in the development of novel drugs targeting neurological and psychiatric disorders.

The chemical structure of 1-(2-Thiazolyl)piperazinedihydrochloride consists of a piperazine ring attached to a thiazole ring, with the entire molecule being protonated and forming a dihydrochloride salt. This structure confers several advantageous properties, such as enhanced solubility and stability, which are crucial for its pharmaceutical applications. The piperazine moiety is known for its ability to interact with various neurotransmitter receptors, while the thiazole ring provides additional functional groups that can be modified to fine-tune the compound's pharmacological profile.

Recent studies have highlighted the potential of 1-(2-Thiazolyl)piperazinedihydrochloride in modulating serotonin and dopamine receptors. These neurotransmitters play key roles in regulating mood, cognition, and behavior, making them important targets for the treatment of conditions such as depression, anxiety, and schizophrenia. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that 1-(2-Thiazolyl)piperazinedihydrochloride exhibits potent serotonin receptor agonist activity, suggesting its potential as an antidepressant agent. Another study in the European Journal of Pharmacology reported that this compound can effectively modulate dopamine D2 receptors, which are implicated in the pathophysiology of schizophrenia.

In addition to its receptor-modulating properties, 1-(2-Thiazolyl)piperazinedihydrochloride has been investigated for its neuroprotective effects. Research conducted at the University of California, Los Angeles (UCLA) found that this compound can reduce oxidative stress and inflammation in neuronal cells, which are common mechanisms underlying neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The neuroprotective potential of 1-(2-Thiazolyl)piperazinedihydrochloride makes it a promising candidate for the development of therapies aimed at slowing or preventing the progression of these debilitating conditions.

The pharmacokinetic properties of 1-(2-Thiazolyl)piperazinedihydrochloride have also been extensively studied to ensure its suitability for clinical use. Preclinical studies have shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles. It has good oral bioavailability and can readily cross the blood-brain barrier, which is essential for its central nervous system (CNS) effects. Furthermore, the compound has demonstrated low toxicity in animal models, indicating a favorable safety profile.

Clinical trials are currently underway to evaluate the efficacy and safety of 1-(2-Thiazolyl)piperazinedihydrochloride in human subjects. Early-phase trials have shown promising results, with participants reporting significant improvements in symptoms associated with depression and anxiety. These findings have paved the way for larger-scale trials to further validate the therapeutic potential of this compound.

Beyond its direct therapeutic applications, 1-(2-Thiazolyl)piperazinedihydrochloride has also been used as a lead compound for drug discovery efforts. Its unique structure serves as a scaffold for the design and synthesis of novel derivatives with enhanced potency and selectivity. For example, researchers at the National Institutes of Health (NIH) have developed several analogs of 1-(2-Thiazolyl)piperazinedihydrochloride that exhibit improved binding affinity to specific neurotransmitter receptors. These analogs are currently being evaluated for their potential as next-generation therapeutics.

In conclusion, 1-(2-Thiazolyl)piperazinedihydrochloride (CAS No. 492431-13-7) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its ability to modulate serotonin and dopamine receptors, coupled with its neuroprotective effects and favorable pharmacokinetic properties, makes it an attractive candidate for the development of novel drugs targeting neurological and psychiatric disorders. Ongoing research and clinical trials will continue to elucidate its full therapeutic potential, paving the way for new treatments that can improve the lives of millions of patients worldwide.

• 209733-13-1(2-(Piperazin-1-yl)thiazole hydrochloride)
• 142287-42-1(1-(3-chloropropyl)-4-(2-thiazolyl)-Piperazine)
• 223514-52-1(Piperazine,1-(5-chloro-2-thiazolyl)-)
• 118113-05-6(1-(5-methyl-1,3-thiazol-2-yl)piperazine)
• 90586-84-8(N-Ethylthiazol-2-amine hydrochloride)
• 42270-37-1(2-piperazin-1-ylthiazole)
• 13472-99-6(N,N-diethyl-1,3-thiazol-2-amine)
• 187533-52-4(1-Methyl-4-(1,3-thiazol-2-yl)piperazine)
• 943430-01-1(1,2-Ethanediamine, N1-methyl-N1-2-thiazolyl-)
• 943512-77-4(3-Azetidinamine, 1-(2-thiazolyl)-)